Portfolio Composition: HTEC

ROBO GLOBAL HEALTHCARE TECHNOLOGY & INNOVATION ETF

47.50down-0.69 (-1.4318%)

 as of 4:10:00pm ET 01/27/2021

ETP's Prospectus Stated Objectives

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the price and yield performance of the ROBO Global® Healthcare Technology and Innovation Index. The fund will normally invest at least 80% of its total assets in securities of the index or in depositary receipts representing securities of the index. The index is designed to measure the performance of companies that have a portion of their business and revenue derived from the field of healthcare technology, and the potential to grow within this space through innovation and market adoption of such companies’ products and services. It is non-diversified.

Asset Classification Equity
Investment Philosophy Passively Managed

ETP Portfolio Characteristics

as of 12/31/2020

Independent third-party analytics of the daily holdings shown below can help you compare the ETP's Prospectus Stated Objectives to the characteristics of its underlying holdings. Their use of standardized calculations enable consistent comparison. It is important to note that they may not reflect ETF Managers' methodology to determine portfolio characteristics in buying and selling securities for the fund. Learn more about the ETF Managers' investment approach and performance in their Prospectus & Reports.

Holdings

Total: 84 (Long: 83 | Short: 1)
Holdings
 Top 10 17.39%
 Other 82.61%

Top 10

EDIT Editas Medicine Inc 2.84%
IRTC iRhythm Technologies Inc 1.83%
ABMD ABIOMED Inc 1.66%
VCRA Vocera Communications Inc 1.62%
IART Integra Lifesciences Holdings Corp 1.61%
CSII Cardiovascular Systems Inc 1.60%
NTRA Natera Inc 1.59%
TRHC Tabula Rasa HealthCare Inc 1.57%
HCAT Health Catalyst Inc 1.55%
FLGT Fulgent Genetics Inc 1.54%
View all Holdings by Weight
Health Care Equipment & Supplies 42.10%
Life Sciences Tools & Services 18.03%
Biotechnology 16.99%
Health Care Technology 8.91%
Health Care Providers & Services 4.50%
Pharmaceuticals 3.31%
Software 2.49%
Semiconductors & Semiconductor Equipment 0.90%
Technology Hardware, Storage & Peripherals 0.86%
Electronic Equipment, Instruments & Components 0.79%
Regional Exposure
North America 81.97%
Europe 14.85%
Asia 2.12%
Africa 0.00%
Middle East 0.00%
Latin America 0.00%
Country Exposure
United States 81.98%
Switzerland 3.69%
France 2.48%
United Kingdom 1.79%
Germany 1.43%
China 1.42%
Italy 1.37%
Netherlands 1.21%
Australia 1.05%
Belgium 1.03%
Market Capitalization
Large 31.70%
Mid 28.09%
Small 25.40%
Micro 14.81%

StyleMap®

as of 01/27/2021   More information
Value Blend Growth
Large
Mid
Small
Current HistoricalCurrent Fund Assets Coverage: 100%
Data provided by .
Free commission offer applies to online purchases select ETFs in a Fidelity brokerage account. The sale of ETFs is subject to an activity assessment fee (from $0.01 to $0.03 per $1,000 of principal). ETFs are subject to market fluctuation and the risks of their underlying investments. ETFs are subject to management fees and other expenses. Unlike mutual funds, ETF shares are bought and sold at market price, which may be higher or lower than their NAV, and are not individually redeemed from the fund.

Data provided by XTF Inc. except where noted. All rights reserved.

Top basket holdings, asset allocation, market sectors, industry exposure, and geographical diversification are as of the date indicated and may not be representative of the funds current or future investments.

For iShares ETFs, Fidelity receives compensation from the ETF sponsor and/or its affiliates in connection with an exclusive long-term marketing program that includes promotion of iShares ETFs and inclusion of iShares funds in certain FBS platforms and investment programs. Please note, this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral. Additional information about the sources, amounts, and terms of compensation can be found in the ETF’s prospectus and related documents. Fidelity may add or waive commissions on ETFs without prior notice. BlackRock and iShares are registered trademarks of BlackRock Inc., and its affiliates.

FBS receives compensation from the funds advisor or its affiliates in connection with a marketing program that includes the promotion of this security and other ETFs to customers ("Marketing Program"). The Marketing Program creates incentives for FBS to encourage the purchase of certain ETFs. Additional information about the sources, amounts, and terms of compensation is in the ETFs prospectus and related documents. Please note that this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral.

Any data, charts and other information provided on this page are intended to help self-directed investors evaluate exchange traded products (ETPs), including, but limited to exchange traded funds (ETFs) and exchange traded notes (ETNs). Criteria and inputs entered, including the choice to make ETP comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a particular security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating ETPs. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use. Determine which securities are right for you based on your investment objectives, risk tolerance, financial situation and other individual factors and re-evaluate them on a periodic basis.

© 2010 Morningstar, Inc. All rights reserved. The Morningstar information contained herein (1) is proprietary to Morningstar or its affiliates; (2) may not be copied or redistributed; and (3) is not warranted to be accurate, complete, or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.

Before investing in any exchange traded product, you should consider its investment objective, risks, charges and expenses. Contact Fidelity for a prospectus, offering circular or, if available, a summary prospectus containing this information. Read it carefully.

888171.1.0